Cell line · CVCL_0234

Caki-1

Cancer cell line, Homo sapiens. Clear cell renal cell carcinoma. 113 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. Caki-1. Cell lines, record CVCL_0234. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0234

On this page

Cell line

As Cellosaurus gives it.

Name: Caki-1
Accession: CVCL_0234
RRID: RRID:CVCL_0234
Synonyms: CAKI-1, CaKi-1, caki-1, CAKI.1, CAKI 1, CAKI1, Caki1
Species: Homo sapiens (Human)
Sex: Male
Age at sampling: 49Y
Category: Cancer cell line
Diseases: Clear cell renal cell carcinoma (NCIt C4033); Clear cell renal carcinoma (ORDO Orphanet_319276)
Derived from: Skin (metastatic)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers113

2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

Paper	Journal	Year	How we know	Source
Inhibition of PLK1 helps to restrict c-Met-induced growth and therapeutic resistance of renal cancer cells.	Mol Cancer Ther	2026	Its Methods give the RRID and name the line	PubMed
Lysyl oxidase drives ccRCC progression by coordinating HIF-2α transcription program with tumor microenvironment.	bioRxiv	2026	Its Methods give the RRID and name the line	PubMed
RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation.	Cancer Med	2026	Its Methods give the RRID and name the line	PubMed
Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification.	Cancer Med	2026	Its Methods give the RRID and name the line	PubMed
IL-8 blockade enhances anti-PD-1 therapeutic activity in renal cell carcinoma in a next-generation patient-derived xenograft model.	iScience	2026	Its Methods give the RRID and name the line	PubMed
USP18 promotes clear cell renal cell carcinoma progression by regulating the ubiquitination and stability of YBX3.	iScience	2026	Its Methods give the RRID and name the line	PubMed
Molecular Glue cc-885 Inhibits VHL-Deficient Clear Cell Renal Cell Carcinoma via ETS1 Degradation.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
ERMP1 Exerts Tumor-Suppressive Functions in KIRC by Inhibiting PI3K/AKT Signaling and Remodeling the Immune Microenvironment: A Pan-Cancer Analysis.	Hum Mutat	2026	Its Methods give the RRID and name the line	PubMed
OSCAR functions as a collagen I receptor to suppress hippo signaling and reprogram lipid metabolism in clear-cell renal cell carcinoma.	Cell Death Dis	2026	Its Methods give the RRID and name the line	PubMed
Global analysis of cancer cell responses to USP9X inhibition.	EMBO J	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 113

See all 113 papers

Relatives8

Relation	Cell line	Accession	Problem	Source
Derived from it	Caki-1-Cas9-593	CVCL_WZ60		Cell lines
Derived from it	Caki-1-Luc	CVCL_J247		Cell lines
Derived from it	Caki-dTub	CVCL_0B30		Cell lines
Derived from it	EDITGENE Caki-1-CopGFP	CVCL_F6BX		Cell lines
Derived from it	EDITGENE Caki-1-FLUC	CVCL_F5UD		Cell lines
Derived from it	HyCyte Caki-1 stable cell line for hANXA1 overexpression	CVCL_F4VP		Cell lines
Derived from it	R1192	CVCL_AT71	Has a recorded problem	Cell lines
Derived from it	SLK	CVCL_9569	Has a recorded problem	Cell lines

Cell banks13

Cell bank	Catalog number	Status	Source
ATCC	HTB-46		ATCC
CLS	300149		CLS
CancerTools	161903		CancerTools
DSMZ	ACC-142	Discontinued	Cellosaurus
DSMZ	ACC-731		DSMZ
EDITGENE	EDC00291		EDITGENE
IZSLER	BS TCL 108		Cellosaurus
JCRB	JCRB0801		JCRB
KCB	KCB 200850YJ		Cellosaurus
KCLB	30046		KCLB

1 to 10 of 13

See all 13 cell banks

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0234

GET https://conductscience.org/api/cell-lines/v1/CVCL_0234/papers?page=2

API reference For AI assistants